ADIPOQ and non-Hodgkin lymphoma: Retrospective studies have reported hyperadiponectinemia in patients with both adult and childhood non-Hodgkin lymphoma (NHL), as well as Hodgkin lymphoma (HL), compared to control groups, with higher adiponectin levels being associated with poorer prognosis and worse clinical outcomes [8, 10, 12].